Advice on the safe introduction and continued use of isotretinoin in acne in the U.K. 2010

British Journal of Dermatology

Volumn 162, Issue 6, 2010, Pages 1172-1179

  Goodfield, M J D ^a   Cox, N H ^b   Bowser, A ^c   McMillan, J C ^c   Millard, L G ^d   Simpson, N B ^e   Ormerod, A D ^f  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b CUMBERLAND INFIRMARY   (United Kingdom)

^c BELFAST CITY HOSPITAL   (United Kingdom)

^d Park Hospital   (United Kingdom)

^e NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^f UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Adverse effects; Depression; Isotretinoin; Pregnancy prevention plan; Safe use; Teratogen

Indexed keywords

ANTIBIOTIC AGENT; BEXAROTENE; ETRETINATE; ISOTRETINOIN; RETINOL;

ACNE; AGGRESSION; ANXIETY; COGNITIVE DEFECT; CONCENTRATION LOSS; CONTRACEPTION; DEPRESSION; DRUG CONTRAINDICATION; DRUG SAFETY; DRUG USE; DRUG WITHDRAWAL; DYSKERATOSIS; HIGH RISK PREGNANCY; HUMAN; INFORMED CONSENT; IRRITABILITY; MANIC PSYCHOSIS; MENTAL DISEASE; MOOD CHANGE; PATIENT COUNSELING; PRACTICE GUIDELINE; PREGNANCY TEST; PRENATAL DRUG EXPOSURE; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; RISK REDUCTION; SCHIZOPHRENIA; SIDE EFFECT; SKIN CANCER; SUICIDE; SUICIDE ATTEMPT; TERATOGENICITY; UNITED KINGDOM;

ABNORMALITIES, DRUG-INDUCED; ACNE VULGARIS; DERMATOLOGIC AGENTS; FEMALE; GREAT BRITAIN; HUMANS; ISOTRETINOIN; MALE; MOOD DISORDERS; PRACTICE GUIDELINES AS TOPIC; PREGNANCY;

EID: 77952712238     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09836.x     Document Type: Review

References (52)

1. Cunliffe WJ, Simpson N. Disorders of the sebaceous glands. In : Rook's Textbook of Dermatology (Burns DA, Breathnach SM, Cox NH, Griffiths CEM, eds 7th edn.
2. Strauss JS, Cunningham WJ, Leyden JJ et al. Isotretinoin and teratogenicity. J Am Acad Dermatol 1988 19 : 353 354.
3. Hazen PG, Carney JF, Walker AE, Stewart JJ. Depression - a side effect of 13-cis-retinoic acid therapy. J Am Acad Dermatol 1983 9 : 278 279.
4. Hanson N, Leachman S. Safety issues in isotretinoin therapy. Semin Cutan Med Surg 2001 20 : 166 183.
5. Josefson D. Acne drug is linked to severe depression. BMJ 1998 316 : 723.
6. U.S. Food and Drug Administration. iPLEDGE 2007 Update. Available at : http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ucm094306.htm (last accessed 28 March 2010).
7. Cunliffe WJ, van de Kerkhof PCM, Caputo R et al. Roaccutane treatment guidelines: Results of an international survey. Dermatology 1997 194 : 351 357.
8. Taibjee SM, Charles-Holmes R. Pitfalls of prescribing acne therapies including isotretinoin for pilots. Br J Dermatol 2007 158 : 653 655.
9. Barth JH, Macdonald-Hull SP, Mark J et al. Isotretinoin therapy for acne vulgaris: A re-evaluation of the need for measurements of plasma lipids and liver function tests. Br J Dermatol 1993 129 : 704 707.
10. Alcalay J, Landau M, Zucker A. Analysis of laboratory data in acne patients treated with isotretinoin: is there really a need to perform routine laboratory tests? J Dermatolog Treat 2001 12 : 9 12.
11. Zane LT, Leyden WA, Marqueling AL, Manos MM. A population-based analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris. Arch Dermatol 2006 142 : 1016 1022.
12. Rodondi N, Darioli R, Ramelet A et al. High risk for hyperlipidemia and the metabolic syndrome after an episode of hypertriglyceridemia during 13-cis retinoic acid therapy for acne: A pharmacogenetic study. Ann Intern Med 2002 136 : 582 589.
13. Restak RM. Pseudotumor cerebri, psychosis and hypervitaminosis A. J Nerv Ment Dis 1972 155 : 72 5.
14. Henderson CA, Highet AS. Depression induced by etretinate. BMJ 1989 298 : 964.
15. Bremner JD. Does isotretinoin cause depression and suicide? Psychopharmacol Bull 2003 37 : 64 78.
16. Meyskens FL Jr. Short clinical reports. J Am Acad Dermatol 1982 6 : 732 734.
17. Krezel W, Ghyselinck N, Samad TA et al. Impaired locomotion and dopamine signaling in retinoid receptor mutant mice. Science 1998 279 : 863 867.
18. Bremner JD, Fani N, Ashraf A et al. Functional brain imaging alterations in acne patients treated with isotretinoin. Am J Psychiatry 2005 162 : 983 991.
19. O'Reilly KC, Shumake J, Gonzalez-Lima F et al. Chronic administration of 13-cis-retinoic acid increases depression-related behavior in mice. Neuropsychopharmacology 2006 31 : 1919 1927.
20. Ferguson SA, Cisneros FJ, Gough B et al. Chronic oral treatment with 13-cis-retinoic acid (isotretinoin) or all-trans-retinoic acid does not alter depression-like behaviors in rats. Toxicol Sci 2005 87 : 451 459.
21. Kontaxakis VP, Skourides D, Ferentinos P et al. Isotretinoin and psychopathology: A review. Ann Gen Psychiatry 2009 8 : 2.
22. Bremner JD, McCaffery P. The neurobiology of retinoic acid in affective disorders. Prog Neuropsychopharmacol Biol Psychiatry 2008 32 : 315 331.
23. Crandall J, Sakai Y, Zhang J et al. 13-cis-retinoic acid suppresses hippocampal cell division and hippocampal-dependent learning in mice. Proc Natl Acad Sci USA 2004 101 : 5111 5116. (Pubitemid 38469211)
24. Gatti S, Serri F. Acute depression from isotretinoin. J Am Acad Dermatol 1991 25 : 132.
25. Byrne A, Hnatko G. Depression associated with isotretinoin therapy. Can J Psychiatry 1995 40 : 567.
26. Scheinman PL, Peck GL, Rubinow DR et al. Acute depression from isotretinoin. J Am Acad Dermatol 1990 22 : 1112 1114.
27. Friedman T, Wohl Y, Knobler HY et al. Increased use of mental health services related to isotretinoin treatment: A 5-year analysis. Eur Neuropsychopharmacol 2006 16 : 413 416.
28. Chia CY, Lane W, Chibnall J et al. Isotretinoin therapy and mood changes in adolescents with moderate to severe acne: A cohort study. Arch Dermatol 2005 141 : 557 560.
29. Rohrback JM, Fleischer AB Jr., Krowchuk DP, Feldman SR. Depression is not common in isotretinoin-treated acne patients. J Dermatolog Treat 2004 15 : 252.
30. Ferahbas A, Turan MT, Esel E et al. A pilot study evaluating anxiety and depressive scores in acne patients treated with isotretinoin. J Dermatolog Treat 2004 15 : 153 157.
31. Cohen J, Adams S, Patten S. No association found between patients receiving isotretinoin for acne and the development of depression in a Canadian prospective cohort. Can J Clin Pharmacol 2007 14 : 227 233.
32. Kaymak Y, Kalay M, Ilter N et al. Incidence of depression related to isotretinoin treatment in 100 acne vulgaris patients. Psychol Rep 2006 99 : 897 906.
33. Ng CH, Tam MM, Celi E et al. Prospective study of depressive symptoms and quality of life in acne vulgaris patients treated with isotretinoin compared to antibiotic and topical therapy. Australas J Dermatol 2002 43 : 262 268.
34. Strahan JE, Raimer S. Isotretinoin and the controversy of psychiatric adverse effects. Int J Dermatol 2006 45 : 789 799.
35. Hull PR, D'Arcy C. Isotretinoin use and subsequent depression and suicide: Presenting the evidence. Am J Clin Dermatol 2003 4 : 493 505.
36. Marqueling AL, Zane LT. Depression and suicidal behavior in acne patients treated with isotretinoin: A systematic review. Semin Cutan Med Surg 2005 24 : 92 102.
37. Medicines and Healthcare Products Regulatory Agency. Download Drug Analysis Prints (DAPs). Available at : http://www.mhra.gov.uk/Onlineservices/ Medicines/Druganalysisprints/index.htm (last accessed 17 December 2009).
38. Wysowski DK, Pitts M, Beitz J. An analysis of reports of depression and suicide in patients treated with isotretinoin. J Am Acad Dermatol 2001 45 : 515 519. (Pubitemid 32917244)
39. Jick SS, Kremers HM, Vasilakis-Scaramozza C. Isotretinoin use and risk of depression, psychotic symptoms, suicide and attempted suicide. Arch Dermatol 2000 136 : 1231 1236.
40. Kellett SC, Gawkrodger DJ. The psychological and emotional impact of acne and the effect of treatment with isotretinoin. Br J Dermatol 1999 140 : 273 282.
41. Rubinow DR, Peck GL, Squillace KM, Gantt GG. Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin. J Am Acad Dermatol 1987 17 : 25 32.
42. Azoulay L, Blais L, Koren G et al. Isotretinoin and the risk of depression in patients with acne vulgaris: A case-crossover study. J Clin Psychiatry 2008 69 : 526 532.
43. Schaffer LC, Schaffer CB, Hunter S, Miller A. Psychiatric reactions to isotretinoin in patients with bipolar disorder. J Affect Disord 2010 122 : 306 308.
44. Barak Y, Wohl Y, Greenberg Y et al. Affective psychosis following Accutane (isotretinoin) treatment. Int Clin Psychopharmacol 2005 20 : 39 41.
45. Millard LG. Adverse mood and behaviour change in young patients on systemic isotretinoin. Br J Dermatol 1999 141 (Suppl. 55 16.
46. Ng CH, Schweitzer I. The association between depression and isotretinoin use in acne. Aust NZ J Psychiatry 2003 37 : 78 84.
47. O'Donnell J. Overview of existing research and information linking isotretinoin (Accutane), depression, psychosis, and suicide. Am J Ther 2003 10 : 148 159.
48. McMullen E, Cox NH. The British Association of Dermatologists isotretinoin questionnaire for patients: A useful clinical tool. Clin Exp Dermatol 2006 31 : 713 714.
49. Jacobs DG, Deutsch NL, Brewer M. Suicide, depression and isotretinoin: is there a causal link? J Am Acad Dermatol 2001 45 : S168 75.
50. Beck AT, Steer RA, Brown GK. Beck Depression Inventory Manual, 2nd edn.
51. Baer L, Jacobs DG, Meszler-Reizes J et al. Development of a brief screening instrument: The HANDS. Psychother Psychosom 2000 69 : 35 41.
52. Peveler R, Carson A, Rodin G. Depression in medical patients. BMJ 2002 325 : 149 152.